{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:00:30Z","timestamp":1786410030822,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00467-020-04644-x","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T03:45:56Z","timestamp":1592624756000},"page":"2183-2189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-3173","authenticated-orcid":false,"given":"Myung Hyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-4408","authenticated-orcid":false,"given":"Yo Han","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8327-7002","authenticated-orcid":false,"given":"Seon hee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8477-0157","authenticated-orcid":false,"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-6209","authenticated-orcid":false,"given":"Il-Soo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-1265","authenticated-orcid":false,"given":"Hae Il","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-5320","authenticated-orcid":false,"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"4644_CR1","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073\u20131086","journal-title":"Lancet"},{"key":"4644_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1086\/644621","volume":"49","author":"LH Gould","year":"2009","unstructured":"Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, Smith K, Shiferaw B, Segler S, Palmer A, Zansky S, Griffin PM (2009) Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 49:1480\u20131485","journal-title":"Clin Infect Dis"},{"key":"4644_CR3","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","volume":"34","author":"M Khalid","year":"2019","unstructured":"Khalid M, Andreoli S (2019) Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 34:2495\u20132507","journal-title":"Pediatr Nephrol"},{"key":"4644_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Holler D, Wurzner R, Karch H (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54:1413\u20131421","journal-title":"Clin Infect Dis"},{"key":"4644_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00467-018-3903-9","volume":"33","author":"L Percheron","year":"2018","unstructured":"Percheron L, Gramada R, Tellier S, Salomon R, Harambat J, Llanas B, Fila M, Allain-Launay E, Lapeyraque AL, Leroy V, Adra AL, Berard E, Bourdat-Michel G, Chehade H, Eckart P, Merieau E, Pietrement C, Sellier-Leclerc AL, Fremeaux-Bacchi V, Dimeglio C, Garnier A (2018) Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study. Pediatr Nephrol 33:1385\u20131394","journal-title":"Pediatr Nephrol"},{"key":"4644_CR6","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/MD.0000000000001000","volume":"94","author":"L Pape","year":"2015","unstructured":"Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (2015) Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94:e1000","journal-title":"Medicine (Baltimore)"},{"key":"4644_CR7","first-page":"854","volume":"130","author":"BS Kaplan","year":"1976","unstructured":"Kaplan BS, Thomson PD (1976) Hyperuricemia in the hemolytic-uremic syndrome. Am J Dis Child 130:854\u2013856","journal-title":"Am J Dis Child"},{"key":"4644_CR8","first-page":"207","volume":"30","author":"S O'Regan","year":"1988","unstructured":"O'Regan S, Rousseau E (1988) Hemolytic uremic syndrome: urate nephropathy superimposed on an acute glomerulopathy? An hypothesis. Clin Nephrol 30:207\u2013210","journal-title":"Clin Nephrol"},{"key":"4644_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2215\/CJN.00350106","volume":"2","author":"AA Ejaz","year":"2007","unstructured":"Ejaz AA, Mu W, Kang DH, Roncal C, Sautin YY, Henderson G, Tabah-Fisch I, Keller B, Beaver TM, Nakagawa T, Johnson RJ (2007) Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2:16\u201321","journal-title":"Clin J Am Soc Nephrol"},{"key":"4644_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","volume":"29","author":"SA Fathallah-Shaykh","year":"2014","unstructured":"Fathallah-Shaykh SA, Cramer MT (2014) Uric acid and the kidney. Pediatr Nephrol 29:999\u20131008","journal-title":"Pediatr Nephrol"},{"key":"4644_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1188\/02.CJON.12-16","volume":"6","author":"JM Brant","year":"2002","unstructured":"Brant JM (2002) Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome. Clin J Oncol Nurs 6:12\u201316","journal-title":"Clin J Oncol Nurs"},{"key":"4644_CR12","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998\u20133003","journal-title":"Blood"},{"key":"4644_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/OTT.S103864","volume":"10","author":"N Alakel","year":"2017","unstructured":"Alakel N, Middeke JM, Schetelig J, Bornhauser M (2017) Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. Onco Targets Ther 10:597\u2013605","journal-title":"Onco Targets Ther"},{"key":"4644_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/omcr\/omu053","volume":"2014","author":"B Zhang","year":"2014","unstructured":"Zhang B, Lee AI, Podoltsev N (2014) Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia. Oxf Med Case Rep 2014:138\u2013140","journal-title":"Oxf Med Case Rep"},{"key":"4644_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","volume":"19","author":"CH Pui","year":"2001","unstructured":"Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GH (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. J Clin Oncol 19:697\u2013704","journal-title":"J Clin Oncol"},{"key":"4644_CR16","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1097\/PCC.0b013e3182192c8d","volume":"12","author":"PY Lin","year":"2011","unstructured":"Lin PY, Lin CC, Liu HC, Lee MD, Lee HC, Ho CS, Chiu NC, Peng CC, Huang FY, Tsai JD (2011) Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke. Pediatr Crit Care Med 12:e424\u2013e427","journal-title":"Pediatr Crit Care Med"},{"key":"4644_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00467-009-1352-1","volume":"25","author":"DJ Hobbs","year":"2010","unstructured":"Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE (2010) Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 25:305\u2013309","journal-title":"Pediatr Nephrol"},{"key":"4644_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00467-011-2047-y","volume":"27","author":"AA Acosta","year":"2012","unstructured":"Acosta AA, Hogg RJ (2012) Rasburicase for hyperuricemia in hemolytic uremic syndrome. Pediatr Nephrol 27:325\u2013329","journal-title":"Pediatr Nephrol"},{"key":"4644_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00467-020-04528-0","volume":"35","author":"A Balestracci","year":"2020","unstructured":"Balestracci A, Meni Battaglia L, Martin SM, Toledo I (2020) Rasburicase in hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli: a report of nine cases. Pediatr Nephrol 35:1133\u20131137","journal-title":"Pediatr Nephrol"},{"key":"4644_CR20","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.thromres.2012.05.017","volume":"130","author":"LB Seltz","year":"2012","unstructured":"Seltz LB, Bakel LA, Tiehen J, Gao D, Cadnapaphornchai MA, Lum G, Ford D (2012) Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. Thromb Res 130:e26\u2013e30","journal-title":"Thromb Res"},{"key":"4644_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"4644_CR22","doi-asserted-by":"crossref","unstructured":"Lee CG, Moon JS, Choi JM, Nam CM, Lee SY, Oh K, Kim YT (2008) Normative blood pressure references for Korean children and adolescents. Korean J Pediatr 51:33\u201341","DOI":"10.3345\/kjp.2008.51.1.33"},{"key":"4644_CR23","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","volume":"28","author":"JM Spinale","year":"2013","unstructured":"Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097\u20132105","journal-title":"Pediatr Nephrol"},{"key":"4644_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12098-014-1606-1","volume":"82","author":"S Jayabose","year":"2015","unstructured":"Jayabose S, Kumar V, Dhanabalan R, Rajan P, Rathnam K, Viswanathan TK (2015) Low-dose rasburicase in hematologic malignancies. Indian J Pediatr 82:458\u2013461","journal-title":"Indian J Pediatr"},{"key":"4644_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/08880018.2017.1348415","volume":"34","author":"KG Gopakumar","year":"2017","unstructured":"Gopakumar KG, Thankamony P, Seetharam S, Kusumakumary P (2017) Treatment of tumor lysis syndrome in children with leukemia\/lymphoma in resource-limited settings-Efficacy of a fixed low-dose rasburicase. Pediatr Hematol Oncol 34:206\u2013211","journal-title":"Pediatr Hematol Oncol"},{"key":"4644_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00431-009-1079-9","volume":"169","author":"A Schifferli","year":"2010","unstructured":"Schifferli A, von Vigier RO, Fontana M, Sparta G, Schmid H, Bianchetti MG, Rudin C (2010) Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003. Eur J Pediatr 169:591\u2013598","journal-title":"Eur J Pediatr"},{"key":"4644_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MNH.0b013e328330d9d0","volume":"18","author":"DI Feig","year":"2009","unstructured":"Feig DI (2009) Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens 18:526\u2013530","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4644_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.ackd.2012.05.009","volume":"19","author":"DI Feig","year":"2012","unstructured":"Feig DI (2012) Hyperuricemia and hypertension. Adv Chronic Kidney Dis 19:377\u2013385","journal-title":"Adv Chronic Kidney Dis"},{"key":"4644_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/MNH.0000000000000061","volume":"23","author":"M Varrier","year":"2014","unstructured":"Varrier M, Ostermann M (2014) Novel risk factors for acute kidney injury. Curr Opin Nephrol Hypertens 23:560\u2013569","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4644_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0025-7125(16)30522-3","volume":"74","author":"JD Conger","year":"1990","unstructured":"Conger JD (1990) Acute uric acid nephropathy. Med Clin North Am 74:859\u2013871","journal-title":"Med Clin North Am"},{"key":"4644_CR31","first-page":"22","volume":"34","author":"E Rousseau","year":"1990","unstructured":"Rousseau E, Blais N, O'Regan S (1990) Decreased necessity for dialysis with loop diuretic therapy in hemolytic uremic syndrome. Clin Nephrol 34:22\u201325","journal-title":"Clin Nephrol"},{"key":"4644_CR32","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00467-012-2181-1","volume":"27","author":"A Balestracci","year":"2012","unstructured":"Balestracci A, Martin SM, Toledo I (2012) Hyperuricemia in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 27:1421\u20131422","journal-title":"Pediatr Nephrol"},{"key":"4644_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442\u2013448","journal-title":"Kidney Int"},{"key":"4644_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2215\/CJN.10410919","volume":"15","author":"RA Noble","year":"2020","unstructured":"Noble RA, Lucas BJ, Selby NM (2020) Long-term outcomes in patients with acute kidney injury. Clin J Am Soc Nephrol 15:423\u2013429","journal-title":"Clin J Am Soc Nephrol"},{"key":"4644_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fped.2018.00220","volume":"6","author":"L Vaterodt","year":"2018","unstructured":"Vaterodt L, Holle J, Huseman D, Muller D, Thumfart J (2018) Short- and long-term renal outcome of hemolytic-uremic syndrome in childhood. Front Pediatr 6:220","journal-title":"Front Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04644-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04644-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04644-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T23:24:49Z","timestamp":1624145089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04644-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4644"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04644-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Seoul Nation University Hospital institutional review board (H-1711-012-895). Due to the characteristics of the study, informed consent from the patients was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}